BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16550865)

  • 1. [Otology manifestations of the Anderson-Fabry disease].
    Pomar Blanco P; San Román Carbajo J; Martín Villares C; Rodríguez Martín F; Paniagua J; Fernández Pello M; Tapia Risueño M
    Acta Otorrinolaringol Esp; 2006 Feb; 57(2):115-7. PubMed ID: 16550865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auditory and vestibular findings in Fabry disease: a study of hemizygous males and heterozygous females.
    Conti G; Sergi B
    Acta Paediatr Suppl; 2003 Dec; 92(443):33-7; discussion 27. PubMed ID: 14989464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The cochlea in Fabry disease: a sensorineural hearing loss model of vascular origin?].
    Malinvaud D; Avan P; Germain DP; Benistan K; Bonfils P
    Rev Med Interne; 2006 Jul; 27(7):527-31. PubMed ID: 16413636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive hearing loss in Fabry's disease: a case report.
    Barras FM; Maire R
    Eur Arch Otorhinolaryngol; 2006 Jul; 263(7):688-91. PubMed ID: 16521018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inner ear involvement in Fabry disease: Clinical and audiometric evaluation of a large cohort of patients followed in a reference centre.
    Rodrigues J; Azevedo O; Sousa N; Cunha D; Mexedo A; Fonseca R
    Eur J Med Genet; 2018 Jun; 61(6):341-347. PubMed ID: 29307789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hearing loss in adult patients with Fabry disease treated with enzyme replacement therapy.
    Suntjens EB; Smid BE; Biegstraaten M; Dreschler WA; Hollak CE; Linthorst GE
    J Inherit Metab Dis; 2015 Mar; 38(2):351-8. PubMed ID: 25395255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anderson-Fabry disease: a multiorgan disease.
    Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Pinto A; Licata G
    Curr Pharm Des; 2013; 19(33):5974-96. PubMed ID: 23448451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vestibular and cochlear manifestations in Fabry's disease].
    Malinvaud D; Germain DP; Benistan K; Bonfils P
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S251-6. PubMed ID: 21211674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperbaric oxygen treatment restores sudden hearing loss in a patient with Fabry disease.
    Frantz MC; Pontz BF; Arnold W
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):210-3. PubMed ID: 18401198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease.
    Ries M; Kim HJ; Zalewski CK; Mastroianni MA; Moore DF; Brady RO; Dambrosia JM; Schiffmann R; Brewer CC
    Brain; 2007 Jan; 130(Pt 1):143-50. PubMed ID: 17105746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inner ear involvement in Anderson-Fabry disease: long-term follow-up during enzyme replacement therapy.
    Sergi B; Conti G; Paludetti G;
    Acta Otorhinolaryngol Ital; 2010 Apr; 30(2):87-93. PubMed ID: 20559478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Auditory and vestibular findings in Fabry disease: a study of 25 patients].
    Pichon M; Lidove O; Roudaire ML; Barry B; Herman P; Gobert D; Pasqualoni E; Compain C; Chauveheid MP; Papo T
    Rev Med Interne; 2012 Jul; 33(7):364-9. PubMed ID: 22365473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hearing loss in Fabry disease: the effect of agalsidase alfa replacement therapy.
    Hajioff D; Enever Y; Quiney R; Zuckerman J; Mackermot K; Mehta A
    J Inherit Metab Dis; 2003; 26(8):787-94. PubMed ID: 14739683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cochleovestibular involvement in patients with Fabry disease: data from the multicenter cohort FFABRY.
    Asquier-Khati A; Mauhin W; Michel G; Gendre A; Durant C; Lavigne C; Maillard H; Lacombe D; Willems M; Lidove O; Masseau A
    Eur Arch Otorhinolaryngol; 2022 Mar; 279(3):1639-1644. PubMed ID: 34825971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac and renal dysfunction is associated with progressive hearing loss in patients with Fabry disease.
    Köping M; Shehata-Dieler W; Cebulla M; Rak K; Oder D; Müntze J; Nordbeck P; Wanner C; Hagen R; Schraven S
    PLoS One; 2017; 12(11):e0188103. PubMed ID: 29161295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabry disease and hearing loss. Comment on: Barras FM, Maire R (2006) Progressive hearing loss in Fabry's disease: a case report. Eur Arch Otorhinolaryngol 263:688-691.
    Sergi B; Conti G
    Eur Arch Otorhinolaryngol; 2007 Feb; 264(2):209. PubMed ID: 17124597
    [No Abstract]   [Full Text] [Related]  

  • 17. Inner ear function in children with Fabry disease.
    Keilmann A
    Acta Paediatr Suppl; 2003 Dec; 92(443):31-2; discussion 27. PubMed ID: 14989463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant hearing loss in Fabry disease: Study of the Danish nationwide cohort prior to treatment.
    Yazdanfard PD; Madsen CV; Nielsen LH; Rasmussen ÅK; Petersen JH; Seth A; Sørensen SS; Køber L; Feldt-Rasmussen U
    PLoS One; 2019; 14(12):e0225071. PubMed ID: 31809513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progression of profound perceptive deafness in children].
    Montalt J; Barona R; Zapater E; Armengot M; Basterra J
    An Otorrinolaringol Ibero Am; 1999; 26(3):225-39. PubMed ID: 10394681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hearing loss in Fabry disease: data from the Fabry Outcome Survey.
    Hegemann S; Hajioff D; Conti G; Beck M; Sunder-Plassmann G; Widmer U; Mehta A; Keilmann A
    Eur J Clin Invest; 2006 Sep; 36(9):654-62. PubMed ID: 16919049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.